Topical Lidocaine-Prilocaine Cream Versus Lidocaine 1% Subcutaneous Infiltration During Nexplanon Insertion: A Randomized Controlled Study
Last updated: 13 Jan 2025
10.21608/ebwhj.2024.249234.1277
Lidocaine, Nexplanon, Subdermal implants
Mohamed
Abdallah
Mahmoud
Department of Obstetrics and Gynecology, Women's Health Hospital, Assiut University
dr_mabdallah1988@yahoo.com
Ahmed
Nasr
Mohamed Ali Ahmed
Department of obstetrics and gynecology, Assiut university, Assiut, Egypt
a_nasr02@lyacos.com
Mohammed
Khalaf
Department of Obstetrics &Gynecology, Women Health Hospital, Faculty of Medicine, Assiut University, Assiut, Egypt
mohkhalf555@yahoo.com
ahmed
Abbas
Department of obstetrics and gynecology, Assiut university, Assiut, Egypt
bmr90@hotmail.com
Eman
El-Said
Department of Obstetrics and Gynecology, Luxor General Hospital, Luxor, Egypt
emanqenawy86@gmail.com
15
15
52902
2025-01-01
2023-11-16
2025-01-01
1
5
2090-7265
2090-7257
https://ebwhj.journals.ekb.eg/article_403715.html
http://journals.ekb.eg?_action=service&article_code=403715
403,715
Original Article
366
Journal
Evidence Based Women's Health Journal
https://ebwhj.journals.ekb.eg/
Topical Lidocaine-Prilocaine Cream Versus Lidocaine 1% Subcutaneous Infiltration During Nexplanon Insertion: A Randomized Controlled Study
Details
Type
Article
Created At
13 Jan 2025